Statins New FDA Warning

Statins New FDA Warning

Postby PharmD » Tue Mar 06, 2012 5:37 pm

Statin can raise blood sugar & HbA1c levels. (JUPITER) Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin trial = 27% inc. in DM - rosuvastatin vs. placebo. (PROVE-IT TIMI 22) Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis In Myocardial Infarction 22 = sub-study: high-dose atorvastatin can worsen glycemic control. Side effects = "rare and unpredictable" serious liver injuries, hyperbilirubinemia, or jaundice (med should be stopped).

Food and Drug Administration. FDA Drug Safety Communication: Important safety label changes to cholesterol-lowering statin drugs. February 28, 2012.
User avatar
PharmD
Site Admin
 
Posts: 165
Joined: Tue Nov 23, 2010 12:29 am

Return to DIABETES

Who is online

Users browsing this forum: No registered users and 1 guest

cron